| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Climb Bio reports Phase 1 data for IgAN drug candidate | ||
| Fr | Stem receives NYSE non-compliance notice on market cap rule | ||
| Fr | Ardelyx presents real-world data on XPHOZAH for hyperphosphatemia | ||
| Fr | ArriVent to present phase 1 data for ARR-217 at ESMO | ||
| Fr | Apex Critical Metals raises $1.86M, begins Nasdaq trading | ||
| Fr | Addnode Group Q3 2026 slides: profit surge 68% on margin gains | ||
| Fr | FDA approves subcutaneous induction regimen for AbbVie's Skyrizi | ||
| Fr | Jefferies raises Zymeworks stock price target on Roche deal | ||
| Fr | Bilia Q3 2026 slides: service business drives record margins | ||
| Fr | Kilroy Q3 2026 slides: record leasing offsets occupancy pressure | ||
| Fr | RBC Capital reiterates Verisk Analytics stock rating at Outperform | ||
| Fr | First Hawaiian Q3 2026 slides: NIM gains offset by credit costs | ||
| Fr | WSFS Q3 2026 slides: wealth revenue surges 30% as ROTCE hits 20.7% | ||
| Fr | Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends | ||
| Fr | Vertex reports positive IgAN trial data, FDA decision due Nov. 30 | ||
| Fr | Roche's sefaxersen shows 43% proteinuria reduction in IgAN trial | ||
| Fr | Macy's declares quarterly dividend of 19.15 cents per share | ||
| Fr | Raymond James reiterates Alnylam stock Strong Buy on positive trial data | ||
| Fr | Jana Small Finance Bank Q2 FY27 slides: record profit drives guidance upgrade | ||
| Fr | GTT Q3 2026 slides: order surge drives record backlog despite revenue dip | ||
| Fr | First Western Q3 2026 slides: earnings surge 88%, margin expands | ||
| Fr | Popular declares $0.90 quarterly dividend per share | ||
| Fr | Wedbush raises Tango Therapeutics stock price target on trial data | ||
| Fr | Bradesco Q3 2026 slides: revenue growth strong amid credit headwinds | ||
| Fr | First Bank Q3 2026 slides: margin expansion drives earnings beat |